Skip to main content

Acrivon Therapeutics, Inc. insider trading

ACRVNASDAQ
$1.99-0.02 (-1.00% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+7.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • EDEric DevroeChief Operating Officer0.3415%of company
  • MMMary MillerChief Legal Officer0.1914%of company
  • ADAdam D. LevyChief Financial Officer0.154%of company
  • EGErick GamelinChief Development Officer0.1227%of company
  • MRMansoor Raza MirzaChief Medical Officer0.0906%of company
  • MLMichaela LevinChief Business Officer0.07%of company
  • RHRasmus Holm-JorgensenChief Financial Officer0.0609%of company
  • KPKatharine PetersonChief Accounting Officer0.0421%of company
  • IMIvana Magovcevic-LiebischDirector0.0219%of company
  • DDDerek DiRoccoDirector0.0219%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
ACRVPeter Blume-JensenPresident and CEOOpen market sell$31K-0.5%$2.21$31KAug 25, 2026Aug 27, 2026
ACRVKatharine PetersonChief Accounting OfficerOpen market sell$203-0.6%$2.01$203Aug 18, 2026Aug 20, 2026
ACRVMary MillerChief Legal OfficerOpen market sell$372-0.2%$2.01$372Aug 18, 2026Aug 20, 2026
ACRVErick GamelinChief Development OfficerOpen market sell$804-0.8%$2.01$804Aug 18, 2026Aug 20, 2026
ACRVEric DevroeChief Operating OfficerOpen market sell$1.21K-0.4%$2.01$1.21KAug 18, 2026Aug 20, 2026
ACRVPeter Blume-JensenPresident and CEOOpen market sell$9730.0%$2.01$973Aug 18, 2026Aug 20, 2026
ACRVPeter Blume-JensenPresident and CEOOpen market sell$2.47K-0.1%$2.01$2.47KAug 18, 2026Aug 20, 2026
ACRVAdam D. LevyChief Financial OfficerOpen market sell$1.79K-1.7%$1.57$1.79KAug 4, 2026Aug 6, 2026
ACRVMary MillerChief Legal OfficerOpen market sell$1.01K-0.7%$1.76$1.01KJul 21, 2026Jul 23, 2026
ACRVPeter Blume-JensenPresident and CEOOpen market purchase$82.3K+2.1%$1.68$82.3KJan 14, 2026Jan 16, 2026
ACRVAdam D. LevyChief Financial OfficerOpen market purchase$15K+72.7%$1.70$15KJan 14, 2026Jan 16, 2026
ACRVEric DevroeChief Operating OfficerOpen market purchase$17.2K+15.3%$1.72$17.2KJan 13, 2026Jan 15, 2026
End of history · 12 transactions
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.